Pancreatic Cancer Research

ResearcherJiangnan UniversityActive in the last 2 years

Hao Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-3006-227X; OpenAlex author ID A5100732978. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 5

  1. Association of HPGDS Expression with Prognosis and Immune Microenvironment Remodeling in Pancreatic Cancer. Co-author DOI 10.2147/cmar.s619196↗
  2. Targeting the ac4C 'Writer' NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells. Co-author DOI 10.1038/s41419-025-08156-0↗
  3. HPGDS as a biomarker for prognosis and immunotherapy in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-6637568/v1↗
  4. Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis:… Co-author DOI 10.1177/11795549241239042↗
  5. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer. Co-author DOI 10.1515/med-2022-0606↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junjing Zhou · 2 shared papers, 2025–2026 · strength 0.53
  2. Jiahua Zhou · 2 shared papers, 2022–2024 · strength 0.40
  3. Haodong Tang · 2 shared papers, 2022–2024 · strength 0.40
  4. Xiaoyun Wang · 1 shared paper, 2026 · strength 0.29
  5. Ge Gao · 1 shared paper, 2025 · strength 0.25
  6. Shuo Zhang · 1 shared paper, 2025 · strength 0.22
  7. Shudong Hu · 1 shared paper, 2025 · strength 0.22
  8. Leisheng Wang · 1 shared paper, 2025 · strength 0.22
  9. Enhong Chen · 1 shared paper, 2025 · strength 0.22
  10. Hao Hu · 1 shared paper, 2025 · strength 0.22
  11. Siyuan Tan · 1 shared paper, 2024 · strength 0.22
  12. Haifeng Li · 1 shared paper, 2024 · strength 0.22
  13. Fangfang Hu · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.